![Ulrich BODENHOFER | Professor for Artificial Intelligence | Professor | Fachhochschule Oberösterreich, Wels | fh-ooe | School of Informatics, Communications and Media | Research profile Ulrich BODENHOFER | Professor for Artificial Intelligence | Professor | Fachhochschule Oberösterreich, Wels | fh-ooe | School of Informatics, Communications and Media | Research profile](https://i1.rgstatic.net/ii/profile.image/1040283743571968-1625034380203_Q512/Ulrich-Bodenhofer.jpg)
Ulrich BODENHOFER | Professor for Artificial Intelligence | Professor | Fachhochschule Oberösterreich, Wels | fh-ooe | School of Informatics, Communications and Media | Research profile
![Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia | Journal of Medicinal Chemistry Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c01418/asset/images/medium/jm2c01418_0012.gif)
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute Leukemia | Journal of Medicinal Chemistry
Önkormányzati hírek Beszámoló a bükkszéki táborról Pálos Települések VIII. Találkozója Interjú Ördögné Bukta M
![István VALÁLIK | h. associate professor | MD, PhD | St. John Hospital, Budapest, Budapest | Department of Neurosurgery | Research profile István VALÁLIK | h. associate professor | MD, PhD | St. John Hospital, Budapest, Budapest | Department of Neurosurgery | Research profile](https://i1.rgstatic.net/ii/profile.image/277068467195917-1443069678245_Q512/Istvan-Valalik.jpg)
István VALÁLIK | h. associate professor | MD, PhD | St. John Hospital, Budapest, Budapest | Department of Neurosurgery | Research profile
![Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours [PeerJ] Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2015/788/1/fig-4-full.png)
Loss of CITED1, an MITF regulator, drives a phenotype switch in vitro and can predict clinical outcome in primary melanoma tumours [PeerJ]
Structure–Activity Relationship of N-Ethyl-Hexedrone Analogues: Role of the α-Carbon Side-Chain Length in the Mechanism of Action, Cytotoxicity, and Behavioral Effects in Mice | ACS Chemical Neuroscience
Targeted Ultrasound-Triggered Phase Transition Nanodroplets for Her2-Overexpressing Breast Cancer Diagnosis and Gene Transfection | Molecular Pharmaceutics
A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity | Journal of Medicinal Chemistry
![Errol PRENS | Professor, MD, PhD | Erasmus MC, Rotterdam | Erasmus MC | Department of Dermatology | Research profile Errol PRENS | Professor, MD, PhD | Erasmus MC, Rotterdam | Erasmus MC | Department of Dermatology | Research profile](https://i1.rgstatic.net/ii/profile.image/381192349208576-1467894746105_Q512/Errol-Prens.jpg)
Errol PRENS | Professor, MD, PhD | Erasmus MC, Rotterdam | Erasmus MC | Department of Dermatology | Research profile
![Christoph DORN | PhD (Dr. rer. nat. habil. med.) | Universität Regensburg, Regensburg | UR | Research profile Christoph DORN | PhD (Dr. rer. nat. habil. med.) | Universität Regensburg, Regensburg | UR | Research profile](https://i1.rgstatic.net/ii/profile.image/279088104263684-1443551197418_Q512/Christoph-Dorn-2.jpg)